The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Glover Stephen C. | Director | Grant(A) | 55K | — | $0 |
| Jan 12, 2026 | Brawley Otis W | Director | Grant(A) | 55K | — | $0 |
| Jan 12, 2026 | Ali-Jackson Kamil | Director | Grant(A) | 55K | — | $0 |
| Jan 12, 2026 | Iliev Ilian | Director | Grant(A) | 55K | — | $0 |
| Jan 12, 2026 | Freitag Gregory Gene | Director | Grant(A) | 55K | — | $0 |
| Jan 12, 2026 | Toutain Stephan | Chief Operating Officer | Grant(A) | 300K | — | $0 |
| Jan 12, 2026 | Brown Spencer D. | Senior VP, General Counsel | Grant(A) | 300K | — | $0 |
| Jan 12, 2026 | Boesgaard Lars | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Jan 12, 2026 | Shepard Kirk V. | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Jan 12, 2026 | Conn Gregory | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Jan 12, 2026 | Bedu-Addo Frank | President/CEO, Director | Grant(A) | 549K | — | $0 |
| Jun 12, 2025 | Toutain Stephan | Chief Operations Officer | Grant(A) | 150K | — | $0 |
| Jun 12, 2025 | Conn Gregory | Chief Scientific Officer | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Boesgaard Lars | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jun 12, 2025 | Brown Spencer D. | Senior VP, General Counsel | Grant(A) | 150K | — | $0 |
| Jun 12, 2025 | Shepard Kirk V. | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Jun 12, 2025 | Bedu-Addo Frank | President/CEO, Director | Grant(A) | 150K | — | $0 |
| Jun 11, 2025 | Glover Stephen C. | Director | Grant(A) | 23K | — | $0 |
| Jun 11, 2025 | Freitag Gregory Gene | Director | Grant(A) | 23K | — | $0 |
| Jun 11, 2025 | Ali-Jackson Kamil | Director | Grant(A) | 23K | — | $0 |
| Jun 11, 2025 | Iliev Ilian | Director | Grant(A) | 23K | — | $0 |
| Jun 11, 2025 | Brawley Otis W | Director | Grant(A) | 23K | — | $0 |
| Feb 28, 2025 | Glover Stephen C. | Director | Buy(P) | 15K | $1.66 | $25K |
| Feb 28, 2025 | Glover Stephen C. | Director | Buy(P) | 15K | — | — |
| Feb 28, 2025 | Freitag Gregory Gene | Director | Buy(P) | 15K | $1.66 | $25K |
| Feb 28, 2025 | Freitag Gregory Gene | Director | Buy(P) | 15K | — | — |
| Jun 24, 2024 | Ali-Jackson Kamil | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2024 | Brawley Otis W | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2024 | Iliev Ilian | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2024 | Sykes Richard | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2024 | Glover Stephen C. | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2024 | Freitag Gregory Gene | Director | Grant(A) | 9K | — | $0 |
| May 1, 2024 | Toutain Stephan | Chief Operations Officer | Grant(A) | 200K | — | $0 |
| Feb 28, 2024 | Conn Gregory | Chief Scientific Officer | Grant(A) | 47K | — | $0 |
| Feb 28, 2024 | Brown Spencer D. | Senior VP, General Counsel | Grant(A) | 56K | — | $0 |
| Feb 28, 2024 | Bedu-Addo Frank | President/CEO, Director | Grant(A) | 300K | — | $0 |
| Jan 22, 2024 | Shepard Kirk V. | Chief Medical Officer | Grant(A) | 200K | — | $0 |
| Dec 4, 2023 | Boesgaard Lars | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jul 14, 2023 | Freitag Gregory Gene | Director | Grant(A) | 9K | — | $0 |
| Jul 14, 2023 | Brawley Otis W | Director | Grant(A) | 9K | — | $0 |
| Jul 14, 2023 | Ali-Jackson Kamil | Director | Grant(A) | 9K | — | $0 |
| Jul 14, 2023 | Sykes Richard | Director | Grant(A) | 9K | — | $0 |
| Jul 14, 2023 | Glover Stephen C. | Director | Grant(A) | 9K | — | $0 |
| Jul 14, 2023 | Iliev Ilian | Director | Grant(A) | 9K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).